<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
	<!-- meta tags-->
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
	<!--external style sheets-->
	<link href="../style.css" type="text/css" rel="stylesheet" />
	
	<style type="text/css">
		li { margin-bottom: .5em; clear: both; }
	</style>

	<title>DCCPS: Comparative Effectiveness Research (CER): Ongoing NCI CER-related activities</title>
</head>

<body>
<div id="skip"><a href="#column-mid2">Skip to main content</a></div>
<div id="wrapper">
    <!-- NCI Banner -->
	<div id="head-row1">
		<img src="../images/dccps-banner2.gif" alt="National Cancer Institute" width="1000" height="40" usemap="#Map" />
	</div>
	<!-- end of NCI Banner -->

    <!-- DCCPS Banner / Search Field -->
	<div id="head-row2">
		<div id="left2">
			<a href="../index.html"><img src="../images/dccps-banner.gif" alt="Cancer Control &amp; Population Sciences Home - NCI's Bridge to Public Health Research, Practice and Policy" width="730" height="68" /></a>
		</div>
		<div id="right2">
			<div id="north">
				<a href="http://twitter.com/NCICancerCtrl" title="Twitter">Twitter<img src="../images/twitter-icon.png" title="Twitter" alt="Twitter" width="20" height="20" /></a><a href="../exit_disclaimer.html"><img src="../images/Icon_External_Link.png" width="12" height="12" alt="exit disclaimer" /></a><a href="../exit_disclaimer.html"><img src="../images/Icon_External_Link.png" width="12" height="12" alt="exit disclaimer" /></a>  <a href="/cr-communication-videos.html" title="Multimedia">Multimedia<img src="../images/media-icon.gif" title="Multimedia" alt="Multimedia" width="20" height="20" /></a>
			</div>
			<form method="get" action="http://search2.google.cit.nih.gov/search" name="search">
				<input type="hidden" name="site" value="DCCPS" />
				<input type="hidden" name="client" value="DCCPS_frontend" />
				<input type="hidden" name="proxystylesheet" value="DCCPS_frontend" />
				<input type="hidden" name="output" value="xml_no_dtd" />
				<input type="hidden" name="filter" value="0" />
				<input type="hidden" name="getfields" value="*" />
				<input id="searchbox" type="text" name="q" size="15" maxlength="255" class="htextf" value="Search" />
				<input type="image" src="../images/hbutton.gif"  class="hbutton" name="btnG" id="btnG" alt="Search" />
			</form>
			<br class="clearfloat" />
		</div>
		<br class="clearfloat" />
	</div>
	<!-- End of DCCPS Banner / Search Field -->
	
	<!-- Main Content -->
	<div id="mainarea">
	<!-- Left Column // DCCPS Link / Need Help Banner -->
	<div id="column-left1">
      	
		<div id="dccps-link">
			<a href="../index.html">Cancer Control &amp; Population Sciences Home</a>
		</div>
		
        <div class="rounded-border">
			<ul class="slist2">
				<li>
                    <a href="index.html">Comparative Effectiveness Research (CER) Home</a>
                    <ul class="cerSiteNav">
                        <li><a href="overview.html">Overview of CER</a></li>
                        <li><a href="priority_setting.html">CER Priority Setting Groups and Reports</a></li>
                        <li><a href="cer_funding.html">CER Funding</a></li>
                        <li><a class="active" href="cer_supported_nci.html">Ongoing CER activities</a></li>
                        <li><a href="resources_links.html">Resources and Links</a></li>
                    </ul>
                </li>
			</ul>
		</div>
		<p><a href="http://www.cancer.gov/help"><img src="../images/help-tile.jpg" alt="Need Help? Contact us by phone (1-800-422-6237), Web, or e-mail" width="200" height="60" class="image1" /></a></p>
    </div>
    <!-- End of Left Column // DCCPS Link / Need Help Banner -->
    
    <!-- Right Column // Page Content -->
    <div id="column-mid2">
        <div class="content">
            <h2>
                Ongoing NCI CER-related activities</h2>
            <ul>
                <li>
                    <img src="images/bmt-logo.jpg" alt="Blood and Marrow Transplant (BMT) Clinical Trials Network logo"
                        style="float: right;" /><a target="_blank" href="https://web.emmes.com/study/bmt2/">Blood and Marrow Transplant (BMT) Clinical
                        Trials Network (CTN)</a><a href="../exit_disclaimer.html"><img src="../images/Icon_External_Link.png"
                            alt="Exit Disclaimer" width="12" height="12" border="0" /></a>: BMT CTN
                    was established in October 2001 to conduct large multi-institutional clinical trials.
                    The trials will address important issues in hematopoietic stem cell transplantation
                    (HSCT), thereby furthering understanding of the best possible treatment approaches.
                    Participating CTN investigators collaborate through an <a target="_blank" href="https://web.emmes.com/study/bmt2/Organization.html">organization</a><a href="../exit_disclaimer.html"><img src="../images/Icon_External_Link.png" alt="Exit Disclaimer" width="12" height="12" border="0" /></a> designed to maintain continuity of operations, to facilitate effective communication and
                    cooperation among participating transplant centers and with collaborators at the
                    National Institutes of Health, and to offer trials participation to patients in
                    all regions of the U.S.</li>
                <li>
                    <img src="images/cisnet.png" alt="Cancer Intervention and Surveillance Modeling Network logo"
                        style="float: right;" /><a target="_blank" href="http://cisnet.cancer.gov/">Cancer Intervention and
                            Surveillance Modeling Network (CISNET)</a>: CISNET is a consortium of NCI-sponsored
                    investigators that use statistical modeling to improve our understanding of cancer
                    control interventions in prevention, screening, and treatment and their effects
                    on population trends in incidence and mortality. These models can be used to guide
                    public health research and priorities.<br />
                    Contact: <a href="mailto:rf41u@nih.gov">Eric J. (Rocky) Feuer, Ph.D.</a></li>
                <li>
                    <img src="images/crn.gif" alt="Cancer Research Network logo" style="float: right;" /><a
                        target="_blank" href="http://crn.cancer.gov/">Cancer Research Network (CRN)</a>: The CRN consists of the research programs, enrolled populations,
                    and data systems of 14 health maintenance organizations nationwide. The overall
                    goal of the CRN, and the NCI initiative under which it was funded, is to use this
                    consortium of delivery systems to conduct research on cancer prevention, early detection,
                    treatment, long-term care, surveillance, and cancer communication and dissemination
                    and implementation research. A portfolio of research studies encompasses cancer
                    control topics ranging from modification of behavioral risk factors such as smoking
                    to cancer care at the end of life.<br />
                    Contact: <a href="mailto:doriarop@mail.nih.gov">Paul Doria-Rose</a></li>
                <li>
                    <img src="images/nci-ccc.png" alt="part of the NCI Community Cancer Centers Program logo"
                        style="float: right;" /><a target="_blank" href="http://ncccp.cancer.gov/">NCI Community Cancer Centers
                            Program</a>: The NCI Community Cancer Centers Program (NCCCP) is a three-year
                    pilot program to test the concept of a national network of community cancer centers
                    to expand cancer research and deliver the latest, most advanced cancer care to a
                    greater number of Americans in the communities in which they live. The NCCCP extends
                    the reach of NCI research into more U.S. states, cities, and towns, including rural
                    areas and inner cities.<br />
                    Contact: <a href="mailto:blanchardf@mail.nih.gov">Frank Blanchard</a></li>
                <li><a target="_blank" href="http://outcomes.cancer.gov/surveys/seer-mhos/">SEER-Medicare Health Outcomes
                    Survey (MHOS) Linkage Project</a>: The Surveillance, Epidemiology, and End Results-Medicare
                    Health Outcomes Survey (SEER-MHOS) linked database is a research resource designed
                    to improve our understanding of the <a target="_blank" href="http://outcomes.cancer.gov/areas/assessment/">
                        health-related quality of life (HRQOL)</a> of cancer patients and survivors
                    enrolled in Medicare health plans. SEER-MHOS is sponsored by the National Cancer
                    Institute (NCI) and the <a target="_blank" href="http://www.cms.hhs.gov/">Centers for Medicare & Medicaid
                        Services (CMS)</a>.</li>
                <li><a target="_blank" href="http://healthservices.cancer.gov/seermedicare/"><span style="font-style: italic;">
                    SEER-Medicare</span> Linked Database</a>: The SEER-Medicare data reflect the linkage
                    of two large population-based sources of data that provide detailed information
                    about elderly persons with cancer. The data come from the SEER program of cancer
                    registries that collect clinical, demographic and cause of death information for
                    persons with cancer and the Medicare claims for covered health care services from
                    the time of a person's Medicare eligibility until death.<br />
                    Contact: <a href="mailto:yaniskoe@imsweb.com">Elaine Yanisko</a></li>
            </ul>
            <h2>
                Featured Clinical Trials</h2>
            <ul>
                <li><a target="_blank" href="http://www.cancer.gov/clinicaltrials/ft-SWOG-S0307">Adjuvant Bisphosphonates
                    for Breast Cancer Trial</a>: Drugs called <a target="_blank" href="http://www.cancer.gov/dictionary/db_alpha.aspx?expand=b#bisphosphonate">
                        bisphosphonates</a> have been shown to slow the progression of bone metastases
                    and reduce skeletal complications in women with metastatic breast cancer. Bisphosphonates
                    may also prevent the development of bone metastases in newly diagnosed patients
                    with no evidence of metastasis. Breast cancer cells stimulate bone cells called
                    osteoclasts, and these osteoclasts in turn stimulate the growth of breast cancer
                    cells. A bisphosphonate called clodronate has been shown to interrupt the relationship
                    between osteoclasts and breast cancer cells in early stage breast cancer. With this
                    trial, the researchers are comparing clodronate with two newer, more-potent bisphosphonates-zoledronate
                    and ibandronate.</li>
                <li>
                    <img src="images/nlst.png" alt="part of the National Lung Screening Trial logo" style="float: right;" /><a
                        href="http://cancer.gov/clinicaltrials/noteworthy-trials/nlst">National Lung Screening
                        Trial</a>: Compares two ways of detecting lung cancer: spiral computed tomography
                    (CT) and standard chest X-ray. Both chest X-rays and spiral CT scans have been used
                    to find lung cancer early. So far, neither chest X-rays nor spiral CT scans has
                    been shown to reduce a person's chance of dying from lung cancer. This study will
                    aim to show if either test is better at reducing deaths from this disease.</li>
                <li><a target="_blank" href="http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=257695&version=HealthProfessional&protocolsearchid=2626313">
                    Prophylactic Removal of Ovaries to Reduce Cancer Risk Trial</a>: This trial examines
                    the impact of preventive surgery (Salpingo-oophorectomy &#150; to remove the ovaries)
                    on quality of life, and the consequences of premature menopause in women at high-risk
                    for ovarian cancer. In addition, there will be genome-wide association studies evaluating
                    polymorphisms in BRCA mutations to refine the model of risk based on specific BRCA
                    mutations. This trial is important because women with mutations in the BRCA1 or
                    BRCA2 genes (genes that normally help to suppress cell growth) face cumulative risks
                    of developing ovarian cancer of 16-40%. For these women, preventive removal of the
                    ovaries and fallopian tubes lowers the risk of ovarian and breast cancer, but the
                    magnitude of these reductions is still uncertain.</li>
                <li><a target="_blank" href="http://prevention.cancer.gov/programs-resources/groups/ed/programs/plco">
                    Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial</a>: The PLCO, is
                    a large-scale clinical trial to determine whether certain cancer screening tests
                    reduce deaths from prostate, lung, colorectal and ovarian cancer. The underlying
                    rationale for the trial is that screening for cancer may enable doctors to discover
                    and treat the disease earlier.</li>
                <li><a target="_blank" href="http://www.cancer.gov/clinicaltrials/digestpage/TAILORx">TAILORx</a>: Testing
                    Personalized Treatment for Breast Cancer The Trial Assigning IndividuaLized Options
                    for Treatment (Rx), or TAILORx, is examining whether genes that are frequently associated
                    with risk of recurrence for women with early-stage breast cancer can be used to
                    assign patients to the most appropriate and effective treatment. TAILORx seeks to
                    incorporate a molecular profiling test (a technique that examines many genes simultaneously)
                    into clinical decision making, and thus spare women unnecessary treatment if chemotherapy
                    is not likely to be of substantial benefit. TAILORx is one of the first trials to
                    examine a methodology for personalizing cancer treatment.</li>
            </ul>
            <p>
                <a target="_blank" href="http://www.cancer.gov/clinicaltrials/search">Search for other Clinical Trials
                    that may be CER</a>.</p>
        </div>
    </div>
    <!-- End of Right Column // Page Content -->
    <br class="clearfloat" />
    </div>
    <!-- End of Main Content -->
    
    <!-- Last Updated -->
    <div class="update">Last Updated: February 25, 2013</div>
    <!-- End of Last Updated -->
    
    <!-- Footer -->
    <div id="foot-row1">
	<ul class="flist2">
    <li><a href="/index.html">Site Home</a></li>
    <li>|</li>
    <li><a href="http://www.cancer.gov/global/contact">Contact Us</a></li>
    <li>|</li>
    <li><a href="http://www.cancer.gov/global/web/policies">Policies</a></li>
    <li>|</li>
    <li><a href="http://www.cancer.gov/global/web/policies/accessibility">Accessibility</a></li>
    <li>|</li>
    <li><a href="http://www.cancer.gov/global/viewing-files">Viewing Files</a></li>
    <li>|</li>
    <li><a href="http://www.cancer.gov/global/web/policies/foia">FOIA</a></li>
    <li>|</li>
	<li><a href="/help.html">Help</a></li>
    <li>|</li>
    <li><a href="/site-map.html">Site Map</a></li>
  </ul>
	<br />

	<ul class="flist2">
    <li><a href="http://www.hhs.gov/">U.S. Department of Health and Human Services</a></li>
    <li>|</li>
  <li><a href="http://www.nih.gov/">National Institutes of Health</a></li>
  <li>|</li>
  <li><a href="http://www.cancer.gov/">National Cancer Institute</a></li>
  <li>|</li>
  <li><a href="http://www.usa.gov/">USA.gov</a></li>
  </ul>
  <div class="nih-tagline">NIH…Turning Discovery Into Health<sup>&#174;</sup></div>
	</div>
    <!-- End of Footer -->
  </div>
<!-- Image map for head-row1 -->
<map name="Map" id="Map">
	<area shape="rect" coords="12,3,294,38" href="http://www.cancer.gov/" alt="National Cancer Institute" />
	<area shape="rect" coords="715,10,892,33" href="http://www.nih.gov" alt="U.S. National Institutes of Health" />
	<area shape="rect" coords="893,10,988,33" href="http://www.cancer.gov/" alt="National Cancer Institute" />
</map>
<!-- End of Image map for head-row1 -->

<!-- GA Code -->
<script type="text/javascript">

  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-25589575-1']);
  _gaq.push(['_trackPageview']);

  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();

</script>
<!-- End of GA Code -->
<script language="JavaScript" type="text/javascript" src="/JS/Omniture/WA_DCCPS_PageLoad.js"></script>
</body>
</html>